Low doses of gamma irradiation potentially modifies immunosuppressive tumor microenvironment by retuning tumor-associated macrophages: Lesson from insulinoma

Carcinogenesis

Volumn 37, Issue 3, 2015, Pages 301-313

  Prakash, Hridayesh ^a,c   Klug, Felix ^a   Nadella, Vinod ^c   Mazumdar, Varadendra ^c   Schmitz Winnenthal, Hubertus ^b,d   Umansky, Liudmila ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF HYDERABAD   (India)

^d KLINIKUM ASCHAFFENBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME INHIBITION; GAMMA IRRADIATION; IN VITRO STUDY; INSULINOMA; MACROPHAGE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE DISTRIBUTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GAMMA RADIATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PANCREAS TUMOR; RADIATION RESPONSE; TRANSGENIC MOUSE; TUMOR ESCAPE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GAMMA RAYS; IMMUNE TOLERANCE; INSULINOMA; MACROPHAGES; MICE; MICE, TRANSGENIC; PANCREATIC NEOPLASMS; PHENOTYPE; TUMOR ESCAPE; TUMOR MICROENVIRONMENT;

EID: 84959885383     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgw007     Document Type: Article

References (39)

1. Gabrilovich, D.I. et al. (2012) Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol., 12, 253-268.
2. Pollard, J.W. (2009) Trophic macrophages in development and disease. Nat. Rev. Immunol., 9, 259-270.
3. Allavena, P. et al. (2008) The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol., 66, 1-9.
4. Sica, A. et al. (2008) Cancer related inflammation: the macrophage connection. Cancer Lett., 267, 204-215.
5. Solinas, G. et al. (2010) Tumor-conditioned macrophages secrete migration- stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J. Immunol., 185, 642-652.
6. Pollard, J.W. (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer, 4, 71-78.
7. Shunyakov, L. et al. (2004) The influence of host response on colorectal cancer prognosis. Clin. Colorectal Cancer, 4, 38-45.
8. Zhang, W. et al. (2010) Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. Clin. Cancer Res., 16, 3420-3430.
9. Beatty, G.L. et al. (2011) CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science, 331, 1612-1616.
10. Schmidt, J. et al. (2007) Impact of interferon-alpha in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): first data from the immunomonitoring. J. Immunother., 30, 108-115.
11. Huang, Z. et al. (2012) Targeted delivery of oligonucleotides into tumorassociated macrophages for cancer immunotherapy. J. Control Release, 158, 286-292.
12. Mifsud, E.J. et al. (2014) TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease. Front. Immunol., 5, 79.
13. Jiang, Z. et al. (2006) Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. Proc. Natl. Acad. Sci. USA, 103, 10961-10966.
14. Edelman, D.A. et al. (2006) Toll-like receptor-4 message is up-regulated in lipopolysaccharide-exposed rat lung pericytes. J. Surg. Res., 134, 22-27.
15. Seong, K.M. et al. (2012) Low-dose radiation induces Drosophila innate immunity through Toll pathway activation. J. Radiat. Res., 53, 242-249.
16. Shin, S.C. et al. (2010) Alteration of cytokine profiles in mice exposed to chronic low-dose ionizing radiation. Biochem. Biophys. Res. Commun., 397, 644-649.
17. Ren, H. et al. (2006) Augmentation of innate immunity by low-dose irradiation. Cell Immunol., 244, 50-56.
18. Ibuki, Y. et al. (1999) Contribution of inflammatory cytokine release to activation of resident peritoneal macrophages after in vivo low-dose gamma-irradiation. J. Radiat. Res., 40, 253-262.
19. Nowosielska, E.M. et al. (2012) Effect of low doses of low-let radiation on the innate anti-tumor reactions in radioresistant and radiosensitive mice. Dose Response, 10, 500-515.
20. Nowosielska, E.M. et al. (2006) Enhanced cytotoxic activity of macrophages and suppressed tumor metastases in mice irradiated with low doses of X- rays. J. Radiat. Res., 47, 229-236.
21. Klug, F. et al. (2013) Low-dose irradiation programs macrophage differentiation to an iNOS/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell, 24, 589-602.
22. Levy, D.E. et al. (2002) What does Stat3 do? J. Clin. Invest., 109, 1143-1148.
23. Bogdan, C. (2001) Nitric oxide and the immune response. Nat. Immunol., 2, 907-916.
24. Monsalve, E. et al. (2009) Notch1 upregulates LPS-induced macrophage activation by increasing NF-kappaB activity. Eur. J. Immunol., 39, 2556-2570.
25. Gazzaniga, S. et al. (2007) Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J. Invest. Dermatol., 127, 2031-2041.
26. Zeisberger, S.M. et al. (2006) Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br. J. Cancer, 95, 272-281.
27. Fink, K. et al. (2009) Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control. Eur. J. Immunol., 39, 2809-2821.
28. Cote, C.K. et al. (2006) Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect. Immun., 74, 469-480.
29. Ma, Y. et al. (2010) Chemotherapy and radiotherapy: cryptic anticancer vaccines. Semin. Immunol., 22, 113-124.
30. Qin, H. et al. (2012) Signal transducer and activator of transcription-3/ suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation. Proc. Natl. Acad. Sci. USA, 109, 5004-5009.
31. Muranski, P. et al. (2008) Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood, 112, 362-373.
32. Tsukimoto, M. et al. (2009) 0.5 Gy gamma radiation suppresses production of TNF-alpha through up-regulation of MKP-1 in mouse macrophage RAW264.7 cells. Radiat. Res., 171, 219-224.
33. Al-Mutairi, M.S. et al. (2010) MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana. PLoS Pathog., 6, e1001192.
34. Wu, J.J. et al. (2006) Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab., 4, 61-73.
35. Bazuine, M. et al. (2004) Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasoneinduced insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol., 18, 1697-1707.
36. Olefsky, J.M. et al. (2010) Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol., 72, 219-246.
37. Zeyda, M. et al. (2007) Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int. J. Obes. (Lond), 31, 1420-1428.
38. Hanahan, D. (1985) Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature, 315, 115-122.
39. Giustarini, D. et al. (2008) Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization. Methods Enzymol., 440, 361-380.